Feasibility, reliability and validity of the Chinese simplified version of the MOS-HIV health survey among AIDS patients in China.
Qual Life Res
; 22(2): 403-7, 2013 Mar.
Article
em En
| MEDLINE
| ID: mdl-22392524
ABSTRACT
PURPOSES:
To test the feasibility, reliability and validity of the Chinese simplified version of the MOS-HIV health survey among AIDS patients in China.METHODS:
A cross-sectional survey of 120 patients receiving highly active antiretroviral treatment was conducted. Feasibility was assessed using the time of administration and the response rate. Reliability was estimated using Cronbach's α. Validity was analyzed by construct and discriminant validity.RESULTS:
The time of administration was about 12 min, and the response rate was 100%. The MOS-HIV showed a good internal reliability and Cronbach's α of eight multi-item scales ranged from 0.75 to 0.91. Correlations between scales were all significant. The majority of the correlations between pairs of scales were within the acceptable range (0.4-0.8). The scores of role function, pain, physical health summary scales were significantly higher for patients with time on antiretroviral treatment >1 year compared to those with time ≤ 1 year. Patients >40 years had significantly higher scores than those of ≤ 40 years on energy and mental health summary scales.CONCLUSIONS:
The Chinese simplified version of MOS-HIV health survey had good feasibility, reliability and validity. It was successfully adapted for AIDS patients in rural areas and could be a valuable tool in evaluating the quality of life of AIDS patients.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Psicometria
/
Qualidade de Vida
/
Infecções por HIV
/
Avaliação de Resultados em Cuidados de Saúde
/
Povo Asiático
Tipo de estudo:
Observational_studies
/
Prevalence_studies
/
Qualitative_research
/
Risk_factors_studies
Limite:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
País/Região como assunto:
Asia
Idioma:
En
Ano de publicação:
2013
Tipo de documento:
Article